Literature DB >> 19125161

Coadministration of coenzyme Q prevents rosiglitazone-induced adipogenesis in ob/ob mice.

M C Carmona1, P Lefebvre, B Lefebvre, A Galinier, A Benani, Y Jeanson, K Louche, S Flajollet, A Ktorza, C Dacquet, L Pénicaud, L Casteilla.   

Abstract

OBJECTIVE: The aim of this study is to determine the effect of coenzyme Q (Q) on ob/ob mice treated or not with thiazolidinedione (TZD). DESIGN AND MEASUREMENTS: Ob/ob mice were treated with Q, Rosiglitazone or a combination of both molecules for 13 days; physical and metabolic parameters as well as oral glucose tolerance test were assessed. mRNA expression of genes of energy dissipation and storage were measured by real-time PCR.
RESULTS: Q treatment improved some metabolic parameters in ob/ob mice. Surprisingly, cotreatment with Rosiglitazone and Q improved metabolic parameters and prevented TZD increase in body weight and adiposity, mainly by increasing lipid oxidation in adipose tissue, reducing lipid synthesis and balancing adipokine gene expression.
CONCLUSIONS: Our finding suggests that Rosiglitazone and coenzyme Q bitherapy could prevent the body weight gain associated with adipogenesis and could improve the clinical use of these compounds.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19125161     DOI: 10.1038/ijo.2008.265

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  7 in total

Review 1.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

2.  The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.

Authors:  Fariba Raygan; Zohreh Rezavandi; Sahar Dadkhah Tehrani; Alireza Farrokhian; Zatollah Asemi
Journal:  Eur J Nutr       Date:  2015-09-18       Impact factor: 5.614

3.  The effects of coenzyme Q10 supplementation on cardiometabolic markers in overweight type 2 diabetic patients with stable myocardial infarction: A randomized, double-blind, placebo-controlled trial.

Authors:  Seyyed Mehdi Mirhashemi; Vajiheh Najafi; Fariba Raygan; Zatollah Asemi
Journal:  ARYA Atheroscler       Date:  2016-07

4.  Clinical Trial of the Effects of Coenzyme Q10 Supplementation on Biomarkers of Inflammation and Oxidative Stress in Diabetic Hemodialysis Patients.

Authors:  Melika Fallah; Gholamreza Askari; Alireza Soleimani; Awat Feizi; Zatollah Asemi
Journal:  Int J Prev Med       Date:  2019-01-15

5.  A Novel Multi-Ingredient Supplement Activates a Browning Program in White Adipose Tissue and Mitigates Weight Gain in High-Fat Diet-Fed Mice.

Authors:  Joshua P Nederveen; Katherine Manta; Adam L Bujak; Alexander C Simone; Matthew R Fuda; Mats I Nilsson; Bart P Hettinga; Meghan C Hughes; Christopher G R Perry; Mark A Tarnopolsky
Journal:  Nutrients       Date:  2021-10-22       Impact factor: 5.717

6.  Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial.

Authors:  Abbas Ali Sangouni; Maryam Taghdir; Javad Mirahmadi; Mojtaba Sepandi; Karim Parastouei
Journal:  Nutr J       Date:  2022-10-03       Impact factor: 4.344

Review 7.  Mitochondrial dysfunction in obesity: potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndrome.

Authors:  Md Ashraful Alam; Md Mahbubur Rahman
Journal:  J Diabetes Metab Disord       Date:  2014-05-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.